
Chart of the Day: NIH Funding Has Stalled Since 2003
The Inflation-Adjusted NIH Budget is Lower in 2024 Than It Was at Its 2003 Peak
Blog Post
Social media outlets such as Twitter enable people, politicians included, to share their knowledge and opinions on topics of concern, including COVID-19. Because the language that politicians use to communicate with their constituents about vaccination may play an important role in vaccine uptake during the pandemic, we were curious about the partisan differences in the language that state and federal legislators used to communicate about vaccination.
In our study, published recently in JMIR Infodemiology, we reported that Republicans were more likely to use words and topics (e.g., “record time,” “Operation Warp Speed success”) that discussed the successful development of the SARS-CoV-2 vaccine. Democrats, on the other hand, were engaged in a broader conversation that was more aligned with public health messaging about the vaccine, using words and terms such as “influenza,” “antivaxxers,” “vaccine prioritization,” and “free.” Republicans tweeted about fewer topics than Democrats, and the keywords associated with Republicans were more highly partisan than those associated with Democrats. Both of these findings are consistent with the presence of more focused, consistent vaccine-related communication from Republican than Democrat legislators. We also found that the political polarization of vaccine-related tweets increased over the study period.
The politically polarized discussion of vaccination on Twitter has the potential to further contribute to vaccine hesitancy. While Twitter content reflects conversations happening outside of digital spaces, it also shapes these conversations. Given the power of the platform, future research needs to directly measure the effect of politicians’ vaccine-related communication on vaccine uptake.
The study, Partisan Differences in Legislators’ Discussion of Vaccination on Twitter During the COVID-19 Era: Natural Language Processing Analysis, was published in JMIR Infodemiology on February 18, 2022. Authors include Eden Engel-Rebitzer, Daniel C. Stokes, Zachary F. Meisel, Jonathan Purtle, Rebecca Doyle, and Alison M. Buttenheim.
The Inflation-Adjusted NIH Budget is Lower in 2024 Than It Was at Its 2003 Peak
Presented to Congressional Committee Staff
But Many Other Factors Played a Role in Denying Loans, LDI Fellow Says
A Simple Change to Clinicians’ Prescribing System Reduced Prescription Disparities by Race, Ethnicity, Insurance Type, and Income
Offit and Buttenheim Criticize HHS Placebo Trial Mandate as Unethical, Misleading, and a Threat to Vaccine Confidence
AcademyHealth Honor Recognizes Early Career Researchers of Exceptional Potential
Honored for Its Work Advancing Health Equity in Health Services Research
Many With High Drug Costs Have Supplemental Coverage and Won’t Reach the $2,000 Out-of-Pocket Cap, a New LDI Study Finds